Valuation: QuidelOrtho Corporation

Market Cap 1.19B 1.04B 959M 886M 1.68B 113B 1.71B 11.46B 4.5B 55.88B 4.47B 4.37B 192B P/E 2026 *
-10.9x
P/E 2027 * -109x
Enterprise Value 3.56B 3.11B 2.87B 2.65B 5.03B 339B 5.12B 34.3B 13.47B 167B 13.36B 13.07B 575B EV / Sales 2026 *
1.31x
EV / Sales 2027 * 1.25x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+4.76%
1 week+1.50%
Current month+4.31%
1 month+35.33%
3 months+31.91%
6 months-45.23%
Current year-36.03%
1 week 15.49
Extreme 15.49
18.77
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Tech/Sci/R&D Officer 44 2024-10-06
Director TitleAgeSince
Director/Board Member 73 2013-12-31
Director/Board Member 62 2024-12-05
Director/Board Member 61 2024-05-14
Date Insider Type Main position Quantity % Market Cap.
06-30Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
06-24Free

Director

22,188 0.0327%
06-24Free

Director

19,599 0.0289%
Change 5-day change 1-year change 3-year change Capi.($)
+4.76%+1.50%-42.09%-78.52% 1.19B
+3.73%+4.72%+10.96%-21.78% 16.67B
+3.87%-0.16%+16.89%+95.61% 1.62B
-2.75%-6.67%-31.97%+27.77% 1.09B
+2.92%-0.94%-28.68%-53.94% 607M
+3.91%-4.55%-38.92%-57.06% 533M
+2.60%+2.89%+29.39%-52.33% 454M
+1.13%+1.30%-55.82%-59.43% 375M
+2.67%-3.08%-24.62%-27.16% 333M
-0.37%-3.80%+12.19%+7.14% 307M
Average +2.20%-2.42%-15.27%-21.97% 2.32B
Weighted average by Cap. +3.38%-0.09%+3.23%-16.72%

Financials

2026 *2027 *
Net sales 2.71B 2.37B 2.19B 2.02B 3.83B 258B 3.9B 26.13B 10.26B 127B 10.18B 9.95B 438B 2.8B 2.45B 2.26B 2.09B 3.96B 267B 4.02B 26.98B 10.6B 132B 10.51B 10.28B 452B
Net income -156M -136M -126M -116M -220M -14.86B -224M -1.5B -590M -7.32B -585M -572M -25.17B -81.93M -71.67M -66.1M -61.05M -116M -7.81B -118M -790M -310M -3.85B -308M -301M -13.23B
Net Debt 2.37B 2.07B 1.91B 1.77B 3.35B 226B 3.41B 22.84B 8.97B 111B 8.89B 8.7B 383B 2.3B 2.01B 1.85B 1.71B 3.25B 219B 3.3B 22.16B 8.7B 108B 8.63B 8.44B 371B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-10 US$18.27 +4.76% 1,278,421
26-07-09 US$17.44 +1.10% 1,074,513
26-07-08 US$17.25 +1.47% 1,756,442
26-07-07 US$17.00 -5.56% 1,179,653
26-07-06 US$18.00 -1.37% 1,059,913
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
17.44USD
Average target price
20.50USD
Spread / Average Target
+17.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock